Literature DB >> 20200654

Human intestinal spirochetosis--a review.

Efstathia Tsinganou1, Jan-Olaf Gebbers.   

Abstract

Human intestinal spirochetosis (IS) is a condition defined histologically by the presence of spirochetal microorganisms attached to the apical cell membrane of the colorectal epithelium. Intestinal spirochetes comprise a heterogeneous group of bacteria. In humans, Brachyspira aalborgi and Brachyspira pilosicoli predominate. Prevalence rates of IS are low where living standards are high, in contrast to poorly developed areas where IS is common. Homosexuals and HIV-infected individuals are at high risk of being colonized. Clinical significance in individual cases has remained unclear up to now. A review of the literature assumes that invasion of spirochetes beyond the surface epithelium may be associated with gastrointestinal symptoms which respond to antibiotic treatment (metronidazole), whereas individuals lacking this feature may be mostly asymptomatic. Of unknown reason, homosexual and HIV-positive men as well as children are more likely to be symptomatic irrespective of invasion. Rare cases of spirochetemia and multiple organ failure have been reported in critically ill patients with IS.

Entities:  

Keywords:  HIV-infection; commensals; human intestinal spirochetosis; intestinal bacterial invasion; microscopic colitis; spirochetemia

Mesh:

Year:  2010        PMID: 20200654      PMCID: PMC2830567          DOI: 10.3205/000090

Source DB:  PubMed          Journal:  Ger Med Sci        ISSN: 1612-3174


Background

First recognized in humans by van Leeuvenhoek in his own diarrheal stool in the 17th century (named as animalcules), intestinal spirochetes in humans are still poorly understood in their biology, origin, and state as commensals or pathogens in the human large intestine. Originally found as a disease of economic devastation in veterinary medicine (e.g. in swine), intestinal spirochetes in humans and its clinical significance have been debated for years [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12]. In 1967, Harland and Lee coined the term intestinal spirochetosis (IS), recognizing the adherence of spirochetes to colorectal epithelium in histology and electron microscopy, the characteristic appearance that is still considered pathognomonic for a possible capacity to cause human disease [2] (Figure 1 (Fig. 1), Figure 2 (Fig. 2), Figure 3 (Fig. 3), Figure 4 (Fig. 4), Figure 5 (Fig. 5)). Despite improvements in the detection and identification of IS, it is still unclear whether this condition represents an actual disease process, or rather, the organisms represent interesting intestinal colonizers in men that does exclusively manifest in the large bowel.
Figure 1

Exfoliative cytology of the rectal mucosa in human spirochetosis with many spirochetes between rod-like bacteriae. Warthin-Starry silver stain. x600.

Figure 2

Histology of human intestinal spirochetosis. Hematoxylin-Eosin. x350.

Figure 3

Human intestinal spirochetosis in the vermiform appendix. Warthin-Starry silver stain. x350.

Figure 4

Immunohistochemical detection of human intestinal spirochetosis with signs of invasion. Strept-Avidin technique. x680.

Figure 5

Human intestinal spirochetosis in transmission electron microscopy. x3500.

Epidemiology

In the veterinary world, IS has been linked to diarrheal illness in swine, poultry, dogs, cats, opossum, non-human primates, and guinea pigs. The disease causes significant economic losses when it affects large numbers of swine, leading to “porridge-like diarrhea”, malnutrition, decreased food intake, and declining growth rates [3]. Human disease is less well understood, though the presence of intestinal spirochetes in stool has been documented microbiologically throughout Africa, Australia, India, Indonesia, and much of the Western world for decades (review: [4]). The prevalence data strongly depend on the material and the detection methods used (direct histology or polymerase chain reaction (PCR) of fecal samples or of colorectal biopsies). A large study in Chicago in the early 1900s revealed a 28% prevalence of intestinal spirochetes in the stools of healthy persons [5]. Studies of stools in West Africa found close to a 100% rate of spirochetes [6]. Prevalence rates in soldiers of Western Command during the early 1900s reached 3.3% in their stools for those with previous bouts of dysentery [7]. It is noteworthy that the presence of spirochetes in the stool might not be associated with IS and with clinical symptoms. In more recent times, the prevalence of intestinal spirochetes in stools appears to correspond with habitation in a developing region. Prevalence rates of 32.6% are seen in Australian aboriginal children. In contrast, spirochaetes were only recovered from 8 of 695 (1.2%) fecal samples that were obtained from other mainly non-Aboriginal children and adults in Western Australia or the Northern Territory of Australia, even though most of these individuals were suffering from gastrointestinal disturbances [8]. Villages in India have shown rates as high as 64.3% in otherwise healthy individuals [6]. A study looking at hospitalized and healthy persons in Oman found prevalence rates of 11.4 and 26.7%, respectively [9]. A study in Bali in 2002 examined 992 fecal samples from people living in rural, urban, and suburban areas. In contrast to the rural predominance seen in earlier studies, prevalence in Bali varied from 3.3 to 23.4%, with the highest percentages in the suburban areas [10]. Other studies reported rates from 1.1 to 5% in most developed countries [4], [6], [13], [14]. The highest rates of colonization of stools with intestinal spirochetes in developed countries are found in homosexual males and in human immunodeficiency virus (HIV)-infected individuals. In the United States, homosexual males have shown rates of colonization as high as 20.6 to 62.5% [4], [15], [16], [17], [18], [19]. The reason for this increased colonization in homosexual men is speculative at best but has caused proponents to ponder whether IS is sexually transmitted [17], [18], [19]. For those with IS and HIV, there appears to be no correlation with degree of immunodeficiency and extent of disease [19]. Colonization of the colonic mucosa with intestinal spirochetes (IS) is not limited to the homosexual population in developed countries, as cases in heterosexual adults have been reported in the U.S., Japan [20], Australia [21], Denmark, Sweden, Switzerland, Norway, England, France [22], Italy, Spain and Brasil [23] (review: [4]). Particularly in children, IS may be associated with severe clinical symptoms [24], [25], [26], [27], [28]. Intestinal spirochetes have been documented in second trimester fetuses while infections by Treponema pallidum, Lyme and relapsing fever Borrelia and Leptospira were ruled out. Fetal tissues showed a brisk lymphocytic-plasmacytic response in the intestinal mucosa. In all instances the placenta had chorioamnionitis and severe chronic villitis. The placental findings suggest an ascending transamniotic infection [29].

Microbiology

As the modern classification of bacteria came to rely on morphologic differences at the level of DNA and RNA, the spirochetes were divided into three phylogenetic groups. The family Spirochaetaceae includes Borrelia, Spirochaeta, Spironema, and Treponema; Leptospiraceae contains Leptonema and Leptospira; and the intestinal spirochetes of Brachyspira (Serpulina) are in the Brachyspiraceae family (Table 1 (Tab. 1)) [30].
Table 1

Classification of Spirochetes [30]

Traditionally, Brachyspira and Serpulina were referred to as separate genera; however, a lack of significant phylogenetic differences has led to the unifying classification under Brachyspira, with the two genus names considered interchangeable [31]. The two members of the Brachyspiraceae family most commonly associated with human IS are Brachyspira aalborgi and Brachyspira pilosicoli. B. aalborgi was first identified in the stool of a patient from Aalborg, Denmark in 1982 [32]. In the years that followed, subsequent cases of IS were assumed to be caused by B. aalborgi on the basis of similar histologic appearance. However, studies published in 1994 and 1996 reexamined the stools using multilocus enzyme electrophoresis and yielded a predominance of B. pilosicoli [33], [34]. Additionally, a study by Trivett-Moore et al. [35], published in 1998, looked at rectal biopsy specimens in homosexual men and found only B. pilosicoli. Following these studies, most subsequent cases of IS were attributed to B. pilosicoli. More recently, PCR-based assays have been used to identify these fastidious organisms (see below). Members of the family Brachyspiraceae are morphologically similar to other spirochetes. The characteristic of all spirochetes, movement through fluid environments, is performed by rotation of flagellae. A central cylinder enclosed by a cytoplasmic membrane is the basic morphologic structure. The periplasmic space contains the axial fibrils, the number of which varies for individual species. Characteristics of B. aalborgi are the length: 2–6 μm; diameter: 0.2 μm; slender, tapered point (causative agent of diarrhea in humans) [11], [12], [36]. Characteristics of the weakly beta hemolytic B. pilosicoli are length: 4–20 μm; diameter: 0.2–0.5 μm; slender, tapered point (causative agent of diarrhea in humans, pigs, dogs, poultry) [3]. Both B. aalborgi and B. pilosicoli are slowly growing fastidious anaerobes, with estimated growth times of 6 days for B. pilosicoli and up to 2 weeks for B. aalborgi [36], [21], [31], [35]. B. aalborgi is difficult to grow on artificial culture media. The first reported isolation of the organism from human feces was on brain heart infusion agar with 10% bovine blood and spectinomycin plus polymyxin B. Incubation in an anaerobic jar allowed growth of larger colonies, and growth was slightly improved at 38.5°C than at 37°C [37], [38]. A report on antimicrobial susceptibility testing of B. pilosicoli was published in 2003 [39]. Antimicrobial susceptibility was determined using Clinical and Laboratory Standards Institute (formerly National Committee for Clinical Laboratory Standards, or NCCLS) breakpoints for anaerobes, with isolates determined to be susceptible to ceftriaxone, chloramphenicol, meropenem, metronidazole, and tetracycline. An arbitrary breakpoint was established for ciprofloxacin, yielding a 60% resistance rate. A slightly better response rate to moxifoxacin was exhibited. Erythromycin was not active against B. pilosicoli, but approximately 30% of erythromycin-resistant isolates were susceptible to clindamycin. The physiology of ruminal and intestinal spirochetes has been reviewed by Stanton in 1998 [40].

Clinical presentation, diagnosis, and treatment

In many cases, the histological findings of IS are simply an incidental discovery during a screening colonoscopy. Symptomatic IS is most commonly accompanied by complaints of chronic (watery) diarrhea and vague abdominal pain without other apparent cause [4]. Though mild to moderate disease symptoms predominate, disease severity can range from asymptomatic to invasive and rapidly fatal. Several cases of invasive disease have been reported [16], [17], [18], [19], [20], [22], [23], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54]. Infected children usually complain of diarrhea and may also present with nausea, weight loss, and failure to thrive [24], [25], [26], [27], [28]. Co-infection with other enteric pathogens, including Enterobius vermicularis, Helicobacter pylori, Shigella flexneri, and Neisseria gonorrhoeae, is common, making the question of clinical significance of IS a difficult one to answer [17], [27], [54]. The endoscopic appearance of the colon lends very little to the diagnosis. A literature review by Alsaigh and Fogt [51] examined the documented endoscopic appearance of 15 biopsy specimens that were histologically consistent with IS. A “polypoid” appearance was noted in seven patients, an “erythematous” area was seen in one patient, a “lesion” was documented in another patient; and normal-appearing mucosa was noted in six patients. Hence, the endoscopic appearance seems to contribute establishing the diagnosis of IS. But probably the spirochetes were found coincidentally in biopsies taken from mucosal areas with irregular appearance, while in most cases the mucosa colonized with spirochetes does not reveal any gross irregularities. Colonic involvement has been documented from the proximal to the distal colon, including the rectum. Involvement of the vermiform appendix has also been reported [36], [45], [55]. The diagnosis of IS is traditionally based on the histological appearance of a diffuse blue fringe (seen in hematoxylin-eosin stain), which is approximately 3 to 6 μm thick, along the border of the intercryptal epithelial layer. This finding is referred to as the “false brush border” [2], [4] (Figure 2 (Fig. 2)). When IS is suspected on the basis of finding a blue fringe, Warthin-Starry or Dieterle silver impregnation stains can be used to highlight the spirochetes in fixed tissue samples (Figure 3 (Fig. 3)) [4], [36], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52]. Recently, an antibody against Borrelia burgdorferi has been applied in the immunohistochemical detection of IS [53] (Figure 4 (Fig. 4)). This is a great diagnostic advantage. On electron microscopy, the spirochetes are seen to dock perpendicularly to the intestinal epithelium [2], [4], [43], [44], [45], [46], [47], [48] (Figure 5 (Fig. 5)). Even with significant diarrhea, the organisms have been described for a long time to be typically non-invasive mainly seen docking onto the cell surface mostly without actually penetrating the membrane [2], [3], [11], [12], [44], [45], [46]. This view has been challenged for the first time in electron microscopic studies; additionally, a particular intraepithelial mast cell and IgE plasma cell reaction has been found [47], [48]. The epithelium undergoes changes, such as blunting and loss of the microvilli, defects of the glycocalyx, and swelling of the mitochondria [11], [12], [47]. Cell-membrane destruction can occur with the spirochetes found in the intercellular spaces, within the surface epithelial cytoplasm as intact organisms, or in phagolysosomes of macrophages as morphological altered spirochetes [47], [48]. The amount of cell destruction usually parallels the degree of invasion microscopically and clinically, with more diarrhea typically seen in those with a greater degree of microvillus destruction and a heavier burden of spirochete attachment [16]. The diarrhea is hypothesized to be a result of decreased resorptive areas of the damaged brush border [46], [48]. Two reports that reviewed histological changes in symptomatic HIV-infected patients with IS noted a higher degree of epithelial invasion, as well as more pronounced loss of microvilli, in this population compared with non-HIV-infected patients [16], [44]. Because diarrhea is common in the HIV-infected population, subtle histologic changes can be easily overlooked, with diarrhea attributed to a cause other than IS. Diagnosis of IS in the HIV-infected population requires pathologists to have a high level of expertise in evaluating biopsy material from HIV-infected individuals [41]. Although the diagnosis of IS is usually made from histological examination of colorectal biopsy material, newer methods for identifying the etiologic organism are being explored but are not yet available commercially. PCR has become one of the more reliable methods, targeting the 16S rRNA, NADH-oxidase, and the 23rDNA gene specific for B. pilosicoli, B. hyodysenteriae, and S. intermedia [56], [57]. Novel techniques such as immunomagnetic separation show promise for the future [58]. Additionally, fluorescent in situ hybridization with oligonucleotide probes targeting 16S or 23S rRNA of B. aalborgi and B. pilosicoli has been reported to be applicable in formalin-fixed, paraffin-embedded intestinal biopsy specimens [59], [60]. Nevertheless, although molecular genetic techniques separate the different spirochetal species specifically, the diagnosis of IS has still to be ascertained morphologically in the biopsy material. Nine cases of bacteremia caused by B. pilosicoli, mostly in immunocompromised or critically ill patients have been reported in the English literature [61], [62], and a specific antibody to B. aalborgi could be obtained from the serum of a patient with IS [63]. Response to antibiotic therapy for IS has varied. While some patients may have complete remission of diarrhea and normalization of the colorectal mucosa, others continue to have diarrhea with or without persistence of the “false brush border”. We suggest that the amount of invasiveness could correlate to the clinical signs and symptoms and that patients with invasion of spirochetes beyond the surface epithelium may be more apt to respond to antibiotic therapy [4]. Generally, a trial of antibiotic therapy is warranted, most commonly with metronidazole. Eradication of symptoms has been reported with metronidazole administered at 500 mg q.i.d. for 10 days [50]. However, there are relatively little data published on recommended treatments other than successful case reports [12], [16], [46], [47], [53], [54]. Symptomatic improvement with the use of other antibiotics, including clindamycin and macrolides, has been reported as well [27].

New perspectives

As the genome sequence of the major swine Brachyspira hyodysenteriae was recently deciphered [64] the genome sequences of other pathogenic and non-pathogenic Brachyspira species are becoming available. This data will facilitate to reveal how these species have evolved and adapted to the varied lifestyles in the complex and changing nutritional and polymicrobial environment of large bowels of different species, and why some but not others can induce colitis and diarrhea [65]. Also, it will be possible to know what survival advantages are gained by Brachyspira species through lateral gene transfer events that seemed to be a dominant evolutionary force in several pathogens [66]. Particularly detailed functional genomic analysis of Brachyspira species may reveal the association with chemotaxis, motility, invasiveness, proteases, hemolysins and other potential virulence factors and allow a differentiation between pathogenic and non-pathogenic strains.

Conclusions

As advances in techniques for the detection of intestinal spirochetes emerge, experts continue to argue about the significance of this condition. Although treatment with effective antibiotic does lead to symptomatic remission and histological clearance in some patients, it is still uncertain whether it was the elimination of the spirochetes that led to the symptomatic improvement. Yet, other patients have no symptomatic relief with treatment despite clearance of spirochetes. Diagnosis of apparent IS made on the basis of histologic examination of biopsy specimens from asymptomatic patients add further to the confusion. On the other hand, the reported cases of IS with septicemia and dissemination provide some validity to the possible consequences of the condition. As IS is more consistently recognized with better identification techniques, it is hoped that the clinical significance of this condition, particularly that of different strains and their potential of invasiveness, will soon become evident.

Notes

Conflicts of interest

None declared.
  58 in total

1.  Spiral-shaped organisms on the surface colonic epithelium of the monkey and man.

Authors:  A Takeuchi; H R Jervis; H Nakazawa; D M Robinson
Journal:  Am J Clin Nutr       Date:  1974-11       Impact factor: 7.045

2.  Intestinal spirochaetosis in children.

Authors:  R M da Cunha Ferreira; A D Phillips; C R Stevens; M J Hudson; H C Rees; J A Walker-Smith
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-10       Impact factor: 2.839

3.  Comparative prevalences of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli as etiologic agents of histologically identified intestinal spirochetosis in Australia.

Authors:  A S Mikosza; T La; W B de Boer; D J Hampson
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

Review 4.  Phylogenetic foundation of spirochetes.

Authors:  B J Paster; F E Dewhirst
Journal:  J Mol Microbiol Biotechnol       Date:  2000-10

5.  Colorectal spirochetosis: clinical significance of the infestation.

Authors:  R H Nielsen; M Orholm; J O Pedersen; K Hovind-Hougen; P S Teglbjaerg; E H Thaysen
Journal:  Gastroenterology       Date:  1983-07       Impact factor: 22.682

6.  Spirochaetosis of the human rectum associated with an intraepithelial mast cell and IgE plasma cell response.

Authors:  J O Gebbers; D J Ferguson; C Mason; P Kelly; D P Jewell
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

7.  Colonic spirochetosis in children and adults.

Authors:  Ayman Koteish; Rajesh Kannangai; Susan C Abraham; Michael Torbenson
Journal:  Am J Clin Pathol       Date:  2003-12       Impact factor: 2.493

8.  Human intestinal spirochetes are distinct from Serpulina hyodysenteriae.

Authors:  J I Lee; A J McLaren; A J Lymbery; D J Hampson
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

9.  In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans.

Authors:  C J Brooke; D J Hampson; T V Riley
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

10.  Spirochaetes as intestinal pathogens: lessons from a Brachyspira genome.

Authors:  David J Hampson; Niyaz Ahmed
Journal:  Gut Pathog       Date:  2009-05-01       Impact factor: 4.181

View more
  29 in total

1.  Bloodstream infection due to Brachyspira pilosicoli in a patient with multiorgan failure.

Authors:  Núria Prim; Roser Pericas; Montse Español; Alba Rivera; Beatriz Mirelis; Pere Coll
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

2.  Impairment of electroneutral Na+ transport and associated downregulation of NHE3 contributes to the development of diarrhea following in vivo challenge with Brachyspira spp.

Authors:  Cole B Enns; Brandon A Keith; Nitin Challa; John C S Harding; Matthew E Loewen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-25       Impact factor: 4.052

Review 3.  The Spirochete Brachyspira pilosicoli, Enteric Pathogen of Animals and Humans.

Authors:  David J Hampson
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

4.  Intestinal spirochetosis: an unusual cause of IBD flare-up during anti-TNF therapy.

Authors:  Julio Maria Fonseca Chebli; Nathália Chebli de Abreu; Liliana Andrade Chebli; Maycon Moura Reboredo; Helady Sanders Pinheiro
Journal:  Int J Colorectal Dis       Date:  2015-05-16       Impact factor: 2.571

5.  Answer to February 2021 Photo Quiz.

Authors:  Laura J Gilbert; Benjamin J Rosen; Roseanne A Ressner
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

6.  Biogeography of the intestinal mucosal and lumenal microbiome in the rhesus macaque.

Authors:  Koji Yasuda; Keunyoung Oh; Boyu Ren; Timothy L Tickle; Eric A Franzosa; Lynn M Wachtman; Andrew D Miller; Susan V Westmoreland; Keith G Mansfield; Eric J Vallender; Gregory M Miller; James K Rowlett; Dirk Gevers; Curtis Huttenhower; Xochitl C Morgan
Journal:  Cell Host Microbe       Date:  2015-02-26       Impact factor: 21.023

7.  Intestinal Spirochetosis in an HIV-positive Patient.

Authors:  Massimiliano Guillermo Trinidad Pereira; Consuelo Martínez Antolinos; Adriana Canosa Fernandez; Elisa Martínez Alfaro; Julián Solís García Del Pozo
Journal:  Eur J Case Rep Intern Med       Date:  2021-07-07

8.  Intestinal spirochaetosis mimicking acute appendicitis with review of the literature.

Authors:  Jason Gan; Catherine Bryant; Dhili Arul; Chetan Parmar
Journal:  BMJ Case Rep       Date:  2017-11-04

9.  Intestinal spirochetosis: an enigmatic disease.

Authors:  Nicholas E Anthony; James Blackwell; William Ahrens; Roger Lovell; Martin W Scobey
Journal:  Dig Dis Sci       Date:  2012-08-01       Impact factor: 3.199

10.  A Case of Human Intestinal Spirochetosis Diagnosed During Screening Colonoscopy.

Authors:  Lynna Alnimer; Ali Zakaria; Bradley Warren
Journal:  Cureus       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.